EUVIMEDEUVIMED entdecken
Fallbericht

A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation

Daisuke Watabe iD, Mitsutoshi Tominaga, Sumika Toyama, Kenji Takamori iD, Hajime Nakano, Hiroo Amano

The Journal of Dermatology · 2023

DOI: 10.1111/1346-8138.16754 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Daisuke Watabe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Iwate Medical University School of Medicine, Yahaba-cho, Japan. Hauptthemen laut MEDLINE: Erythromelalgia, Small Fiber Neuropathy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary erythromelalgia (PEM) is a rare condition characterized by severe burning pain, erythema, and increased temperature in the extremeties. Mutations in the Nav1.7 sodium channel encoded by the SCN9A are responsible for PEM. The pathophysiology of PEM is unclear, but the involvement of neurogenic and vasogenic mechanisms has been suggested. Here we report a case of severe PEM in a 9‐year‐old child with a novel SCN9A mutation and examine the distribution of nerve fibers and expression of neuropeptides in the affected skin. Gene mutation analysis revealed a novel mutation p.L951I (c.2851C>A) in the heterozygous form of the SCN9A . An immunofluorescence study showed that intraepidermal nerve fibers were decreased in the affected leg, suggesting small fiber neuropathy. There was no increase in the expression of substance P (SP) or calcitonin gene‐related peptide (CGRP) in the lesional skin tissue. These findings suggest SP and CGRP do not play a major role in the pathophysiology of primary erythromelalgia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythromelalgiaSmall Fiber NeuropathyChildHumansNAV1.7 Voltage-Gated Sodium ChannelCalcitonin Gene-Related PeptidePainMutation

Stichwörter der Autor:innen

CGRPSCN9Aneuropeptidesprimary erythromelalgiasubstance P

Substanzen

NAV1.7 Voltage-Gated Sodium ChannelCalcitonin Gene-Related PeptideSCN9A protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Iwate Medical University School of Medicine, Yahaba-cho, Japan.
  • Juntendo Itch Research Center, Institute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Urayasu, Japan.
  • Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

ORCID-Profile: Daisuke Watabe, Kenji Takamori

Zitieren

APA

Watabe, D., Tominaga, M., Toyama, S., Takamori, K., Nakano, H., & Amano, H. (2023). A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16754

Vancouver

Watabe D, Tominaga M, Toyama S, Takamori K, Nakano H, Amano H. A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16754

BibTeX
@article{Watabe2023,
  author = {Watabe, Daisuke and Tominaga, Mitsutoshi and Toyama, Sumika and Takamori, Kenji and Nakano, Hajime and Amano, Hiroo},
  title = {A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation},
  journal = {The Journal of Dermatology},
  year = {2023},
  doi = {10.1111/1346-8138.16754}
}
Kostenlos starten →